PROVIDER PROFILE · NPI 1770744716

Ana KiessM.D., PH.D.

Radiation OncologyBaltimore, MDI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

763

Unique beneficiaries

—

Total services

2,892

Distinct HCPCS

Medicare payment

$345K

Peer benchmark

Total Medicare services vs. 95 Radiation Oncology providers in MD — top quintile (cohort median 2,543).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$40K

Distinct drugs

Brand share

54.0%

Top prescribed drugs

Relugolix15 claims

Oxycodone Hcl12 claims

Venlafaxine Hcl12 claims

Tamsulosin Hcl11 claims

QUALITY · MIPS · 2024

Final MIPS score

83.3

Quality

73.9

Cost

70.5

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.35%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Ana Kiess's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Harry Quon Radiation Oncology · Baltimore, MD	30	1,034
Phuoc Tran Radiation Oncology · Houston, TX	23	286
Daniel Song Radiation Oncology · Baltimore, MD	20	192
Hyunseok Kang Medical Oncology · Palo Alto, CA	19	357
Stephanie Terezakis Radiation Oncology · Minneapolis, MN	16	136
HERMAN, JOSEPH	15	94
Fariba Asrari Radiation Oncology · Baltimore, MD	14	236
SIMPSON, MARISSA	14	160

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history